> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Medtronic Indication for Onyx Stents
- URL: https://www.fdaweb.com/fda-approves-medtronic-indication-for-onyx-stents/
- Published: 2022-09-22T12:00:00.000Z
- Updated: 2026-09-14T18:00:14.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152800

FDA has approved the treatment of non-left main bifurcation lesions with the Medtronic provisional bifurcation stenting technique using the Onyx Frontier and Resolute Onyx drug-eluting stents. Medtronic [says](https://news.medtronic.com/Medtronic-is-the-first-and-only-company-to-receive-FDA-indication-for-bifurcation-percutaneous-coronary-intervention-with-a-drug-eluting-stent?ref=fdaweb.com) it is the only company to be approved for this indication in the U.S.

The company says bifurcation lesions occur when plaque builds up around the junction of two coronary arteries. They are considered challenging to treat, it says, because of anatomical variations in the vessels and the difficulty associated with reaching the side branches.